随着常频机械通气(CMV)策略的改进,高频通气(HFV)、肺表面活性物质、体外膜肺(ECMO)以及吸入一氧化氮(NO)的应用,新生儿呼吸道疾病死亡率显著降低,愈来愈多的危重新生儿、早产儿、极低体重儿存活。然而在努力降低通气压力和需氧浓度情况下,呼吸机相关性肺损伤依然存在,呼吸窘迫综合征(RDS)治愈存活的早产儿慢性肺部疾患 The mortality of neonatal respiratory disease was significantly reduced with the improvement of the CMV strategy, HFV, pulmonary surfactant, ECMO and inhaled NO. , More and more critically ill newborns, premature children, very low birth weight children survive. However, ventilatory-associated lung injury persists in efforts to reduce ventilatory pressure and aerobic concentrations, and chronic respiratory distress syndrome (RDS) is cured of surviving chronic lung disease